GSK Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Mar 24, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, transaction
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on March 24, 2025, that it purchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount involved in these transactions.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This filing is a routine report of share transactions and does not indicate any new material risks.
Key Players & Entities
- GSK plc (company) — Registrant
- Citigroup Global Markets Limited (company) — Corporate stockbroker executing share purchases
- March 2025 (date) — Reporting period for the transaction
FAQ
What specific number of GSK ordinary shares were purchased?
The filing states that a 'number' of ordinary shares were purchased but does not specify the exact quantity.
What was the total dollar amount spent on the share repurchases?
The filing does not disclose the total dollar amount of the share repurchases.
On what exact date did the share purchase occur?
The filing indicates the reporting period is for the month of March 2025 and mentions 'Date of purchase:' but does not provide a specific date.
Who acted as GSK's corporate stockbroker for these transactions?
Citigroup Global Markets Limited acted as GSK's corporate stockbroker.
Does GSK file annual reports under Form 20-F or Form 40-F?
GSK indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 24, 2025 regarding GSK plc (GLAXF).